Casdin Capital »

AgomAb Therapeutics NV shares owned by Casdin Capital

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Casdin Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $16M 1.6M 10.49

More positions owned by Casdin Capital

Revolution Medicines (RVMD)
Genedx Holdings Corp Com Cl A (WGS)
Relay Therapeutics (RLAY)
Biolife Solutions Com New (BLFS)
D Fluidigm Corp Del (LAB)
Illumina (ILMN)
Structure Therapeutics Sponsored Ads (GPCR)
10x Genomics Cl A Com (TXG)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Guardant Health (GH)
Neurogene (NGNE)
Alnylam Pharmaceuticals (ALNY)
Maze Therapeatics (MAZE)
Scholar Rock Hldg Corp (SRRK)

View all positions for Casdin Capital

Top funds holding AgomAb Therapeutics NV

Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
Nantahala Capital Management
Standard Life Aberdeen
Perceptive Advisors
Samsara BioCapital
LMR Partners
Seven Grand Managers
Redmile Group
Millennium Management
Alyeska Investment Group

View all funds holding AgomAb Therapeutics NV